EUVIMEDEUVIMED entdecken
BeobachtungsstudieQuerschnittstudieOpen Access

Effect of Metformin on Peripheral Nerve Morphology in Type 2 Diabetes: A Cross-Sectional Observational Study

Roshan Dhanapalaratnam iD, Tushar Issar iD, Leiao Leon Wang, Darren Tran, Ann M Poynten, Kerry-Lee Milner, Natalie C G Kwai, Arun V Krishnan iD

Diabetes · 2024

DOI: 10.2337/db24-0365 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetes, 2024. Verfasst von Roshan Dhanapalaratnam und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Hypoglycemic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic peripheral neuropathy (DPN) affects ∼50% of the 500 million people with type 2 diabetes worldwide and is considered disabling and irreversible. The current study was undertaken to assess the effect of metformin on peripheral neuropathy outcomes in type 2 diabetes. Participants with type 2 diabetes (n = 69) receiving metformin were recruited and underwent clinical assessment, peripheral nerve ultrasonography, nerve conduction studies, and axonal excitability studies. Also concurrently screened were 318 participants who were not on metformin, and 69 were selected as disease control subjects and matched to the metformin participants for age, sex, diabetes duration, BMI, HbA1c, and use of other diabetes therapies. Medical record data over the previous 20 years were analyzed for previous metformin use. Mean tibial nerve cross-sectional area was lower in the metformin group (metformin 14.1 ± 0.7 mm2, nonmetformin 16.2 ± 0.9 mm2, P = 0.038), accompanied by reduction in neuropathy symptom severity (P = 0.021). Axonal excitability studies demonstrated superior axonal function in the metformin group, and mathematical modeling demonstrated that these improvements were mediated by changes in nodal Na+and K+conductances. Metformin treatment is associated with superior nerve structure and clinical and neurophysiological measures. Treatment with metformin may be neuroprotective in DPN. Article Highlights

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminDiabetes Mellitus, Type 2Diabetic NeuropathiesHypoglycemic AgentsNeural ConductionHumansMaleFemaleCross-Sectional StudiesMiddle AgedAgedPeripheral NervesTibial NerveAxonsUltrasonography

Substanzen

MetforminHypoglycemic Agents

Autor:innen und Institutionen

  • School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • Department of Neurology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
  • Department of Endocrinology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
  • School of Medical, Indigenous and Health Sciences, University of Wollongong, Wollongong, New South Wales, Australia.

ORCID-Profile: Roshan Dhanapalaratnam, Tushar Issar, Arun V Krishnan

Zitieren

APA

Dhanapalaratnam, R., Issar, T., Wang, L. L., Tran, D., Poynten, A. M., Milner, K. L., Kwai, N. C. G., & Krishnan, A. V. (2024). Effect of Metformin on Peripheral Nerve Morphology in Type 2 Diabetes: A Cross-Sectional Observational Study. Diabetes. https://doi.org/10.2337/db24-0365

Vancouver

Dhanapalaratnam R, Issar T, Wang LL, Tran D, Poynten AM, Milner KL, et al. Effect of Metformin on Peripheral Nerve Morphology in Type 2 Diabetes: A Cross-Sectional Observational Study. Diabetes. 2024. doi:10.2337/db24-0365

BibTeX
@article{Dhanapalaratnam2024,
  author = {Dhanapalaratnam, Roshan and Issar, Tushar and Wang, Leiao Leon and Tran, Darren and Poynten, Ann M and Milner, Kerry-Lee and Kwai, Natalie C G and Krishnan, Arun V},
  title = {Effect of Metformin on Peripheral Nerve Morphology in Type 2 Diabetes: A Cross-Sectional Observational Study},
  journal = {Diabetes},
  year = {2024},
  doi = {10.2337/db24-0365}
}
Kostenlos starten →